Quarterly report pursuant to Section 13 or 15(d)

Subsequent Event (Tables)

v3.10.0.1
Subsequent Event (Tables)
6 Months Ended
Jun. 30, 2018
Subsequent Events [Abstract]  
Pro Forma Shareholder's Equity Table

The following table sets forth the Company’s Total Shareholders’ Equity position as of June 30, 2018, as adjusted on a pro forma basis to reflect the recently completed underwritten Public Offering:

Oragenics, Inc.

Pro Forma Shareholder’s Equity

(U.S. dollars)

 

Total Shareholders’ Equity as of June 30, 2018

   $ 3,650,580     

Net Proceeds from July 17, 2018 Public Offering

     12,300,000     
  

 

 

    

 

 

 

Pro forma Total Shareholders’ Equity, as of June 30, 2018, as adjusted

   $ 15,950,580